DUBLIN–(BUSINESS WIRE)–The “Global Homatropine Methylbromide Market 2021-2027” report has been added to ResearchAndMarkets.com’s offering.
The global homatropine methylbromide market is anticipated to grow at a considerable CAGR during the forecast period. The rising incidences of peptic ulcers in the geriatric population are expected to drive the market growth for the global homatropine methylbromide market.
According to the NCBI, with age, the prevalence of gastric and duodenal ulcers rose. Females have a significantly lower incidence of duodenal and stomach ulcers than men in patients under 60 years old. In H. pylori-infected individuals, the prevalence of duodenal and stomach ulcers was significantly greater than in those who did not have H. pylori infection.
Homatropine is used to treat ulcers in the duodenum and stomach, as well as intestinal issues. In the treatment of peptic ulcers, it can be used with antacids or other medications. The global homatropine methylbromide market is segmented based on type. Based on type, the market is segmented into injectables and tablets.
Geographically, the global homatropine methylbromide market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.
Some of the companies operating in the global homatropine methylbromide market include Centroflora, Hubei Biocause Pharmaceutical, Pioneer Agro Industries, Resonance Laboratories, Saurav Chemicals, Vital Laboratories.
Market Segmentation
- Global Homatropine Methylbromide Market Research and Analysis by Type
The Report Covers
- Comprehensive research methodology of the global homatropine methylbromide market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global homatropine methylbromide market.
- Insights about market determinants that are stimulating the global homatropine methylbromide market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Homatropine Methylbromide Market By Type
4.1.1. Injectables
4.1.2. Tablets
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Centroflora
6.2. Hubei Biocause Pharmaceutical
6.3. Pioneer Agro Industries
6.4. Resonance Laboratories
6.5. Saurav Chemicals
6.6. Vital Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/m1aaxl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900